The elevated CRMP2 was prominently attenuated by diabetic onset in DM (vs. DIO) and CRC-DM (vs. colitis-CRC) mice, supporting the significantly decreased CRMP2 in CRC patients with diabetic comorbidity. Here, DPYSL2 is linked to colorectal carcinoma.